Intellectual Property India Publishes Patent Application for Neutralizing And Protective Monoclonal Antibodies Against Respiratory Syncytial Virus (rsv)

MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202617069298 A) filed by The United States Of America, As on June 02, 2026, for Neutralizing And Protective Monoclonal Antibodies Against Respiratory Syncytial Virus (rsv).

Inventor includes Khurana, Surender Number.

The application for the patent was published on July 03, 2026, under issue no. 27/2026.

Abstract: Antibodies and antigen binding fragments that specifically bind to an attachment (G) protein of RSV are disclosed. Nucleic acids encoding these antibodies, vectors and host cells are also provided. The disclosed antibodies, antigen binding fragments, nucleic acids and vectors can be used, for example, to reduce disease in a subject with an R...